Skip to main content

Table 2 Distribution of St Gallen molecular subgroups in primary breast tumours and matched lymph node metastases

From: St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial

   Molecular phenotype in lymph node metastases Total
N  
   Luminal A Luminal B HER2-positive Triple negative  
Molecular phenotype in breast tumour luminal A 38 (85) 5 (11) 0 2 (4) 45 (100)
luminal B 0 17 (100) 0 0 17 (100)
HER2-positive 0 1 (9) 10 (91) 0 11 (100)
N (%) Triple negative 0 0 1 (8) 11 (92) 12 (100)
  Total 38 23 11 13 85 (100)
  1. p = 0.06 McNemar-Bowker test of symmetry for all subclasses.
  2. p = 0.02 McNemar-Bowker test of symmetry for Luminal A subclass versus non-Luminal A subclasses.
  3. N = number of patients, percentages are given within parenthesis.